Persistent hiccup as an adverse effect of amisulpride in a patient with first episode of psychosis.

Introduction A 28-year old male patient was admitted involuntarily to the 4th PICU of the Mental Health Hospital of Thessaloniki, due to severe psychotic symptoms and disorganised behaviour. Upon mental health examination the symptoms included auditory hallucinations, tangible speech, delusional id...

Full description

Bibliographic Details
Main Authors: I. Retsou, D. Antoniadis
Format: Article
Language:English
Published: Cambridge University Press 2023-03-01
Series:European Psychiatry
Online Access:https://www.cambridge.org/core/product/identifier/S0924933823021405/type/journal_article
_version_ 1797616873995501568
author I. Retsou
D. Antoniadis
author_facet I. Retsou
D. Antoniadis
author_sort I. Retsou
collection DOAJ
description Introduction A 28-year old male patient was admitted involuntarily to the 4th PICU of the Mental Health Hospital of Thessaloniki, due to severe psychotic symptoms and disorganised behaviour. Upon mental health examination the symptoms included auditory hallucinations, tangible speech, delusional ideas of somatic and persecutory type and significant neglect of his personal hygiene. The onset of his psychotic illness was 3 years prior, with two hospitalizations in the UK, and several unsuccessful attempts of outpatient monitoring. Objectives The study of persistent hiccup as an adverse effect of antipsychotic medication. Methods Monitoring for adverse effects during admission. Results On the 8th day of admission, oral olanzapine 10 mg was commenced at night. On the 9th day, olanzapine was increased to 20 mg per day. Discontinuation of intramuscular medication occurred on the 16th day. After presenting no clinical improvement for 27 days with the administration of olanzapine as monotherapy, amisulpride at 2ml per day was initiated alongside the Olanzapine. In the context of medication titration, amisulpride reached 8ml per day, equivalent to 800mg per day after 2 months of hospitalisation. Conclusions Apart from minor constipation, no other gastrointestinal health problems were reported in his records. The onset of the hiccups occurred along the dosages of 800mg/day of amisulpride and 20mg/day of olanzapine. There was a satisfactory response to treatment evidenced by a 30% reduction on the Positive scale of the PANSS, however, the hiccups did not recede. Disclosure of Interest None Declared
first_indexed 2024-03-11T07:47:33Z
format Article
id doaj.art-b9254928298748ce98b4eebb97b53940
institution Directory Open Access Journal
issn 0924-9338
1778-3585
language English
last_indexed 2024-03-11T07:47:33Z
publishDate 2023-03-01
publisher Cambridge University Press
record_format Article
series European Psychiatry
spelling doaj.art-b9254928298748ce98b4eebb97b539402023-11-17T05:07:25ZengCambridge University PressEuropean Psychiatry0924-93381778-35852023-03-0166S1008S100910.1192/j.eurpsy.2023.2140Persistent hiccup as an adverse effect of amisulpride in a patient with first episode of psychosis.I. Retsou0D. Antoniadis14th PICU, Mental Health Hospital of ThessalonikiSchool of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece Introduction A 28-year old male patient was admitted involuntarily to the 4th PICU of the Mental Health Hospital of Thessaloniki, due to severe psychotic symptoms and disorganised behaviour. Upon mental health examination the symptoms included auditory hallucinations, tangible speech, delusional ideas of somatic and persecutory type and significant neglect of his personal hygiene. The onset of his psychotic illness was 3 years prior, with two hospitalizations in the UK, and several unsuccessful attempts of outpatient monitoring. Objectives The study of persistent hiccup as an adverse effect of antipsychotic medication. Methods Monitoring for adverse effects during admission. Results On the 8th day of admission, oral olanzapine 10 mg was commenced at night. On the 9th day, olanzapine was increased to 20 mg per day. Discontinuation of intramuscular medication occurred on the 16th day. After presenting no clinical improvement for 27 days with the administration of olanzapine as monotherapy, amisulpride at 2ml per day was initiated alongside the Olanzapine. In the context of medication titration, amisulpride reached 8ml per day, equivalent to 800mg per day after 2 months of hospitalisation. Conclusions Apart from minor constipation, no other gastrointestinal health problems were reported in his records. The onset of the hiccups occurred along the dosages of 800mg/day of amisulpride and 20mg/day of olanzapine. There was a satisfactory response to treatment evidenced by a 30% reduction on the Positive scale of the PANSS, however, the hiccups did not recede. Disclosure of Interest None Declaredhttps://www.cambridge.org/core/product/identifier/S0924933823021405/type/journal_article
spellingShingle I. Retsou
D. Antoniadis
Persistent hiccup as an adverse effect of amisulpride in a patient with first episode of psychosis.
European Psychiatry
title Persistent hiccup as an adverse effect of amisulpride in a patient with first episode of psychosis.
title_full Persistent hiccup as an adverse effect of amisulpride in a patient with first episode of psychosis.
title_fullStr Persistent hiccup as an adverse effect of amisulpride in a patient with first episode of psychosis.
title_full_unstemmed Persistent hiccup as an adverse effect of amisulpride in a patient with first episode of psychosis.
title_short Persistent hiccup as an adverse effect of amisulpride in a patient with first episode of psychosis.
title_sort persistent hiccup as an adverse effect of amisulpride in a patient with first episode of psychosis
url https://www.cambridge.org/core/product/identifier/S0924933823021405/type/journal_article
work_keys_str_mv AT iretsou persistenthiccupasanadverseeffectofamisulprideinapatientwithfirstepisodeofpsychosis
AT dantoniadis persistenthiccupasanadverseeffectofamisulprideinapatientwithfirstepisodeofpsychosis